Pfizer Settles Trade Secret Lawsuit Over ‘Revolutionary’ Drug

May 31, 2023, 8:11 PM UTC

Pfizer Inc. settled a lawsuit against two former employees and their company, Regor Therapeutics Inc., that alleged they stole trade secrets related to a purported “revolutionary” diabetes and obesity treatment.

The US District Court for the District of Connecticut dismissed the case Wednesday after the parties said they’d reached a settlement in principle Tuesday. The settlement comes after Pfizer withdrew one of its trade secrets claims and agreed to strike portions of an expert report. Settlement details aren’t publicly available, and Pfizer spokesperson Pamela Eisele declined to comment further.

The pharmaceutical company claimed Min Zhong and Xiayang Qiu set ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.